Insider Profile
Dent, Roger
$CNO $OML
2
Companies Filed At
1
Open-Market Buys (2yr)
$38K
Buy Value (2yr, open-market)
Sep 21, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Sep 21, 2026 $OML
Omni-Lite Industries Canada Inc.
— Exercise Sell 35,000 $1.13 $40K —
Sep 21, 2026 $OML
Omni-Lite Industries Canada Inc.
— Exercise Buy 35,000 $1.13 $40K —
Sep 21, 2026 $OML
Omni-Lite Industries Canada Inc.
— Exercise Buy 170,213 — — —
Aug 31, 2026 $CNO
California Nanotechnologies Corp.
— Exercise Buy 9,769 $0.39 $4K 55
Aug 31, 2026 $CNO
California Nanotechnologies Corp.
— Exercise Buy 97,276 $0.17 $17K 55
Aug 31, 2026 $CNO
California Nanotechnologies Corp.
— Exercise Sell 9,769 $0.39 $4K 55
Aug 31, 2026 $CNO
California Nanotechnologies Corp.
— Exercise Sell 97,276 $0.17 $17K 55
Mar 23, 2026 $CNO
California Nanotechnologies Corp.
— Open Market Sell 500,000 $0.30 $150K 55
Oct 15, 2025 $CNO
California Nanotechnologies Corp.
— Comp. Grant Buy 90,000 $0.39 $35K 55
Aug 22, 2025 $CNO
California Nanotechnologies Corp.
— Exercise Buy 163,974 — — 55
Aug 22, 2025 $CNO
California Nanotechnologies Corp.
— Exercise Sell 77,724 $0.17 $14K 55
Aug 22, 2025 $CNO
California Nanotechnologies Corp.
— Exercise Sell 61,250 $0.10 $6K 55
Aug 22, 2025 $CNO
California Nanotechnologies Corp.
— Exercise Sell 25,000 $0.07 $2K 55
Feb 24, 2025 $CNO
California Nanotechnologies Corp.
— Open Market Buy 50,000 $0.75 $38K 55
Oct 21, 2024 $CNO
California Nanotechnologies Corp.
— Exercise Buy 60,000 $0.05 $3K 55
Oct 21, 2024 $CNO
California Nanotechnologies Corp.
— Exercise Sell 60,000 $0.05 $3K 55
Oct 21, 2024 $CNO
California Nanotechnologies Corp.
— Exercise Sell 50,000 $0.07 $4K 55
Oct 21, 2024 $CNO
California Nanotechnologies Corp.
— Exercise Sell 38,250 $0.10 $4K 55
Oct 21, 2024 $CNO
California Nanotechnologies Corp.
— Exercise Buy 50,000 $0.07 $4K 55
Oct 21, 2024 $CNO
California Nanotechnologies Corp.
— Exercise Buy 38,250 $0.10 $4K 55
Nov 29, 2023 $CNO
California Nanotechnologies Corp.
— Exercise Buy 75,000 $0.05 $4K 55
Nov 29, 2023 $CNO
California Nanotechnologies Corp.
— Exercise Sell 75,000 $0.05 $4K 55
Nov 15, 2023 $OML
Omni-Lite Industries Canada Inc.
— Open Market Buy 50,000 $0.70 $35K —
Oct 30, 2023 $CNO
California Nanotechnologies Corp.
— Open Market Sell 300,000 $0.15 $45K 55
Oct 30, 2023 $CNO
California Nanotechnologies Corp.
— Open Market Sell 600,000 $0.15 $90K 55
Oct 30, 2023 $CNO
California Nanotechnologies Corp.
— Open Market Sell 674,447 $0.15 $101K 55
Oct 23, 2023 $CNO
California Nanotechnologies Corp.
— Open Market Sell 387,224 $0.25 $97K 55
Aug 28, 2023 $CNO
California Nanotechnologies Corp.
— Comp. Grant Buy 175,000 $0.17 $31K 55
Jun 15, 2023 $CNO
California Nanotechnologies Corp.
— Exercise Buy 50,000 $0.05 $2K 55
Jun 15, 2023 $CNO
California Nanotechnologies Corp.
— Exercise Sell 50,000 $0.05 $2K 55
Aug 05, 2022 $CNO
California Nanotechnologies Corp.
— Comp. Grant Buy 100,000 $0.10 $10K 55
Jun 30, 2022 $CNO
California Nanotechnologies Corp.
— Expiry Sell 25,000 — — 55
Feb 22, 2022 $CNO
California Nanotechnologies Corp.
— Comp. Grant Buy 75,000 $0.07 $6K 55
Feb 14, 2021 $OML
Omni-Lite Industries Canada Inc.
— Expiry Sell 10,000 $1.48 $15K —
Nov 20, 2020 $CNO
California Nanotechnologies Corp.
— Open Market Buy 15,000 $0.09 $1K 55
Nov 20, 2020 $CNO
California Nanotechnologies Corp.
— Open Market Buy 10,000 $0.09 $850 55
Nov 18, 2020 $CNO
California Nanotechnologies Corp.
— Open Market Buy 150,000 $0.09 $14K 55
Nov 16, 2020 $CNO
California Nanotechnologies Corp.
— Open Market Buy 35,000 $0.09 $3K 55
Oct 19, 2020 $OML
Omni-Lite Industries Canada Inc.
— Expiry Sell 50,000 $1.98 $99K —
Aug 04, 2020 $CNO
California Nanotechnologies Corp.
— Comp. Grant Buy 60,000 $0.06 $3K 55
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.